Molbio Diagnostics
Price Band
₹768 - ₹807
Lot Size
18 Shares
Issue Size
₹939.70 Cr
Fresh Issue
₹200.00 Cr
OFS
₹739.70 Cr
Registrar
AI Sentiment Score
Listing Price
₹980.00
vs Issue: ₹807 (+21.44%)
📅 IPO Timeline
✓
Open
Aug 10
✓
Close
Aug 12
✓
Allotment
Aug 13
✓
Refund
Aug 14
✓
Demat
Aug 14
✓
Listing
Aug 17
✨ AI Analysis & Prediction
+10.2%
predicted listing gain
The baseline GMP of 14.87% is adjusted upwards significantly due to extraordinary QIB demand (186.39x), which typically signals strong institutional appetite and listing pops. While the high OFS component creates a slight structural drag, the consistent revenue growth and absence of debt provide a strong fundamental cushion.
💪 Strengths
- Proprietary Truenat portable PCR platform
- Strong revenue and PAT growth trajectory
- Zero or negligible debt profile
⚠️ Weaknesses
- High percentage of Offer for Sale (OFS) in issue structure
- Concentration in a specialized diagnostic niche
🚀 Opportunities
- Expansion of decentralized healthcare in resource-limited settings
- Development of new diagnostic assays for non-communicable diseases
🛡️ Threats
- Intense competition from established diagnostic chains
- Regulatory changes in medical device certifications
🎯 Objectives of the IPO
| Requirement / Purpose | Amount (₹ Cr) |
|---|---|
| Funding capital expenditure towards the setting up of infrastructure for our research and development facility, Center of Excellence and connected office space. | ₹118.08 |
| Funding capital expenditure towards the purchase of certain plant, machinery and other equipment for Goa Unit I, Goa Unit II and Visakhapatnam Unit, and | ₹79.04 |
| General corporate purposes | ₹742.58 |
📊 Key Financials
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| Revenue (₹ Cr) | 840.66 | 1,027.94 | 1,455.17 |
| PAT (₹ Cr) | 83.54 | 138.58 | 164.14 |
📋 Live Subscription Status
QIB
186.39x
NII
47.76x
Retail
12.97x
Total
70.27x
Updated: Aug 18, 2026 8:08 AM
📈 Shareholding & Anchor Lock-In
🔗 Important Links & Lead Managers
- Check Allotment StatusCheck Now →
- Registrar WebsiteVisit →
- Download DRHP ProspectusDownload PDF 📥
- Download RHP ProspectusDownload PDF 📥
Lead Managers / Merchant Bankers
This issue is managed by Hem Securities Ltd., and Share India Capital Services Pvt. Ltd.
Disclaimer: The information provided on this page is for educational and informational purposes only and does not constitute financial advice. IPO investments are subject to market risks. AI-generated analysis is based on publicly available data and may not be accurate. Grey Market Premium (GMP) is unofficial and highly speculative. Always consult a qualified financial advisor and read the DRHP/RHP carefully before making investment decisions.